Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

LLY

Lilly(Eli) & Co

Dec 24 • 04:00PM ET

795.67

Dollar change -0.61
Percentage change -0.08	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE MRK JNJ BMY GILD AMGN ABBV REGN BIIB VRTX

| Held by: VTI VOO SPY IVV VUG XLV IWF VHT QUAL IVW

Scroll to Statements

Index	S&P 500	P/E	87.04	EPS (ttm)	9.14	Insider Own	10.39%	Shs Outstand	950.22M	Perf Week	2.19%
Market Cap	755.34B	Forward P/E	35.11	EPS next Y	22.66	Insider Trans	-0.67%	Shs Float	850.67M	Perf Month	6.37%
Income	8.37B	PEG	2.64	EPS next Q	5.48	Inst Own	72.76%	Short Float	0.68%	Perf Quarter	-13.94%
Sales	40.86B	P/S	18.48	EPS this Y	108.29%	Inst Trans	5.53%	Short Ratio	1.54	Perf Half Y	-11.72%
Book/sh	14.99	P/B	53.09	EPS next Y	72.16%	ROA	12.54%	Short Interest	5.79M	Perf Year	39.50%
Cash/sh	3.71	P/C	214.68	EPS next 5Y	33.00%	ROE	65.75%	52W Range	567.64 - 972.53	Perf YTD	36.50%
Dividend Est.	5.34 (0.67%)	P/FCF	539.61	EPS past 5Y	13.74%	ROI	19.34%	52W High	-18.19%	Beta	0.40
Dividend TTM	5.20 (0.65%)	Quick Ratio	0.97	Sales past 5Y	9.91%	Gross Margin	80.91%	52W Low	40.17%	ATR (14)	23.14
Dividend Ex-Date	Feb 14, 2025	Current Ratio	1.27	EPS Y/Y TTM	68.88%	Oper. Margin	35.33%	RSI (14)	50.66	Volatility	3.10% 2.50%
Employees	43000	Debt/Eq	2.19	Sales Y/Y TTM	27.41%	Profit Margin	20.48%	Recom	1.58	Target Price	1008.45
Option/Short	Yes / Yes	LT Debt/Eq	2.04	EPS Q/Q	1780.56%	Payout	77.91%	Rel Volume	0.31	Prev Close	796.28
Sales Surprise	-5.44%	EPS Surprise	-16.97%	Sales Q/Q	20.43%	Earnings	Oct 30 BMO	Avg Volume	3.75M	Price	795.67
SMA20	0.24%	SMA50	-2.52%	SMA200	-5.15%	Trades		Volume	1,165,383	Change	-0.08%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$360 → $375
Mar-06-23	Initiated	Jefferies	Hold	$290
Feb-15-23	Downgrade	Societe Generale	Hold → Sell
Nov-18-22	Initiated	Credit Suisse	Outperform	$395
Sep-22-22	Upgrade	UBS	Neutral → Buy	$335 → $363

Show Previous Ratings

Dec-25-24 07:12AM	Jim Cramer Says Novo Nordisk A/S (NVO) Cant Exceed Eli Lilly (Insider Monkey)
06:53AM	Eli Lilly and Co (LLY) Is Among Billionaire Colemans Top Picks (Insider Monkey)
06:30AM	Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst (Yahoo Finance Video)
Dec-24-24 09:00PM	The Big Companies Funding Trumps Inauguration Despite Denouncing Jan. 6 (The Wall Street Journal)
05:45PM	Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know (Zacks)
02:45PM	Loading…
02:45PM	What's next for GLP-1 weight-loss drugs in 2025? (Yahoo Finance Video)
12:20PM	3 biggest catalysts expected for healthcare in 2025 (Yahoo Finance Video)
09:38AM	Retail investors buy Novo dip after disappointing weight-loss drug data (Reuters)
Dec-23-24 04:42PM	S&P 500 Gains and Losses Today: Chip Stocks Surge as Holiday Trading Week Begins (Investopedia)
04:28PM	These Stocks Moved the Most Today: Honda, Qualcomm, Broadcom, Lilly, ResMed, Tesla, Walmart, Rumble, and More (Barrons.com)
03:46PM	Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength. (Barrons.com)
02:45PM	These Stocks Are Moving the Most Today: Honda, Qualcomm, Broadcom, Lilly, ResMed, Tesla, Walmart, Rumble, and More (Barrons.com)
02:25PM	Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound (Investopedia)
01:33PM	Top Stock Movers Now: Broadcom, AMD, ResMed, and More (Investopedia)
12:10PM	Eli Lilly, Qualcomm, Rumble: Market Minute (Yahoo Finance Video)
11:36AM	Loading…
11:36AM	Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea (Investopedia)
09:22AM	FDA approves Lillys obesity med Zepbound to treat obstructive sleep apnoea (Pharmaceutical Technology)
09:00AM	Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:32AM	Eli Lillys UK life sciences investment a pivotal moment, says analyst (Pharmaceutical Technology)
07:22AM	Hot Obesity Drug Market Will Keep Investors Gripped Next Year (Bloomberg)
04:15AM	Does This News From the FDA Make Eli Lilly a Buy for 2025? (Motley Fool)
04:00AM	Most significant clincal trials of 2024 (Clinical Trials Arena)
Dec-22-24 05:16PM	Analyst Report: Eli Lilly and Company (Morningstar Research)
05:34AM	3 Stocks That Could Join the Trillion-Dollar Market Cap Club Next Year (Motley Fool)
Dec-21-24 08:43AM	2 Dividend-Growth Stocks That Billionaire Izzy Englander Loves (Motley Fool)
07:30AM	Novo obesity data positive for Eli Lilly and Amgen, says UBS (TipRanks)
07:25AM	Weight loss seen with Novos CagriSema weaker than expected, says BofA (TipRanks)
04:55AM	Is Now a Good Time to Buy the Dip in Eli Lilly Stock? (Motley Fool)
Dec-20-24 08:05PM	Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients (The Wall Street Journal)
05:59PM	Novo Nordisk Stock Crashes on Obesity Drug Data. Its a Win for Eli Lilly. (Barrons.com)
05:58PM	Loading…
05:58PM	Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? (Investor's Business Daily)
05:00PM	The FDA just approved Eli Lilly's Zepbound for sleep apnea and Medicare coverage could be next (Quartz)
04:32PM	FDA approves Zepbound (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity (PR Newswire)
04:11PM	Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge. (Investor's Business Daily)
02:05PM	Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture (CNBC TV)
01:27PM	Top Stock Movers Now: Carnival, US Steel, Occidental Petroleum, and More (Investopedia)
01:09PM	Novos Obesity Shot Shortfall Shows Danger of Promising Too Much (Bloomberg)
01:07PM	Theres a New Obesity King (The Wall Street Journal)
12:20PM	Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up (Motley Fool)
11:52AM	Novo Crashes 19% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump. (Investor's Business Daily)
11:38AM	Ozempic makers shares plunge after failed weight-loss trial (The Telegraph)
11:09AM	Novo Nordisk's New Weight-Loss Drug Lags Behind Eli Lilly's Zepbound (GuruFocus.com)
11:03AM	Novo Nordisk stock sees biggest loss in more than 20 years on CagriSema results (Yahoo Finance)
11:03AM	Novo Nordisk stock sees biggest loss in 20 years on CagriSema results (Yahoo Finance)
10:31AM	Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? (Investor's Business Daily)
10:23AM	Novo Nordisk Plunges 20% After Weight-Loss Drug Trial Misses Target (GuruFocus.com)
10:14AM	Why Novo Nordisk (NVO) Is Plummeting Today (Insider Monkey)
09:39AM	Novo Nordisk stock plunges on obesity shot trial results (Yahoo Finance Video)
09:15AM	November PCE, govt. shutdown looms, Novo Nordisk: 3 Things (Yahoo Finance Video)
08:33AM	Novo Nordisk Falls Most on Record After New Weight Drug Disappoints (Bloomberg)
08:17AM	Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump. (Investor's Business Daily)
08:03AM	Novo Nordisk Sinks on Disappointing Trial Results for Next Gen Weight Loss Drug (Investopedia)
08:00AM	Is Eli Lilly Stock A Buy After FDA Pushes Back On Compounded Knockoffs? (Investor's Business Daily)
07:39AM	FDA confirms end of Eli Lillys tirzepatide shortage after re-evaluation (Pharmaceutical Technology)
07:18AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:08AM	Novo Nordisk Stock Crashes More Than 20% After Disappointing Obesity Drug Data. Eli Lilly Shares Soar. (Barrons.com)
05:51AM	Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints (Reuters)
05:00AM	Ozempic lures people to the doctor, Nestle's GLP-1 'shot,' an FDA Zepbound ruling: Pharma news roundup (Quartz)
05:00AM	Nestle's GLP-1 'shot,' the FDA's Zepbound ruling, and Ozempic lures people to the doctor: Pharma news roundup (Quartz)
02:06AM	Novos next-gen obesity drug misses expectations in closely watched trial (BioPharma Dive)
Dec-19-24 08:03PM	In weight loss battle, Novo and Lilly face growing offensive from licensed copies (Reuters)
04:22PM	Jim Cramer on Eli Lilly and Company (LLY): I See Things Going Back To Normal For Eli Lilly (Insider Monkey)
04:21PM	Novo Is Ready to Ramp Up GLP-1 Manufacturing Following $11B Factory Deal (Barrons.com)
04:18PM	IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List (Investor's Business Daily)
04:03PM	Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls (Yahoo Finance Video)
03:57PM	FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next (Yahoo Finance)
03:38PM	The FDA says the Zepbound shortage is over. That's rattling the weight loss industry (Quartz)
03:02PM	FDA says knockoff versions of Lilly obesity drug must come off the market (Associated Press Finance)
02:16PM	FDA Says Shortage of Eli Lillys Zepbound Is Over, but Gives Compounders a Grace Period (Barrons.com)
12:15PM	The FDA's Zepbound ruling is rattling the weight-loss industry. Here's why (Quartz)
10:14AM	Eli Lillys Zepbound Shortage Is Officially Over, FDA Says (Barrons.com)
06:38AM	Zepbound, Mounjaro shortages are resolved, FDA confirms (BioPharma Dive)
05:26AM	These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy? (Motley Fool)
04:44AM	This Is Huge News for Eli Lilly Investors (Motley Fool)
12:05AM	Healthcare Stocks Had a Dismal Year. Therein Lies Opportunity, Says This Analyst (Barrons.com)
Dec-18-24 11:12AM	Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments (PR Newswire)
10:25AM	Merck Licenses a Weight-Loss Pill. Its Bad News for Obesity Biotechs. (Barrons.com)
07:36AM	FDA targets more online vendors selling unapproved GLP-1RA products (Pharmaceutical Technology)
06:15AM	Ozempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss Drug (Motley Fool)
06:01AM	Gan and Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial) (PR Newswire)
05:11AM	Eli Lilly Is Putting Dividend Growth Stocks to Shame With Yet Another Huge Increase to Its Payout (Motley Fool)
04:38AM	Egyptian Drug Authority approves Lilly and EVAs insulin injection (Pharmaceutical Technology)
02:39AM	Big Pharmas new DTC play: partnering with digital health providers (Pharma Voice)
Dec-17-24 08:50PM	Eli Lilly's Alzheimer's treatment approved in China (Dec. 17) (Reuters)
08:00PM	Lilly's Kisunla (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease (PR Newswire)
05:45PM	Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know (Zacks)
09:45AM	15 Billion Reasons to Love Eli Lilly Stock Right Now (Motley Fool)
06:00AM	Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt (PR Newswire)
03:21AM	Sanofi sues HHS to defend 340B rebate policy (Healthcare Dive)
Dec-16-24 05:03PM	Novos New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. (Barrons.com)
08:47AM	The Weight-Loss Drug Market Is Heading for a Reckoning This Week (Barrons.com)
06:06AM	EMA CHMP recommends Lillys Crohns therapy for EU approval (Pharmaceutical Technology)
Dec-15-24 06:55PM	Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca (pirtobrutinib) in Mainland China (PR Newswire)
02:05PM	2 Brand-New Reasons to Buy Eli Lilly Stock Right Now, and 2 Reasons to Be Cautious (Motley Fool)
08:17AM	Did Eli Lilly Just Say "Checkmate" to Novo Nordisk? (Motley Fool)
06:40AM	2 Weight Loss Stocks That Are Screaming Buys in December (Motley Fool)
06:07AM	3 Unstoppable Stocks to Buy Right Now (Motley Fool)
Dec-14-24 12:17AM	Why Is Eli Lilly and Company (LLY) Among the Best Income Stocks to Buy According to Analysts? (Insider Monkey)
Dec-13-24 10:03AM	Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling. (Barrons.com)
08:11AM	Lilly's Omvoh (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn's disease (PR Newswire)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM
LILLY ENDOWMENT INC	10% Owner	Sep 03 '24	Sale	966.69	24,084	23,281,840	96,891,978	Sep 04 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 27 '24	Sale	968.46	24,552	23,777,668	96,916,062	Aug 28 04:05 PM
Zakrowski Donald A	Officer	Aug 26 '24	Proposed Sale	950.00	750	712,500		Aug 26 04:47 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 26 '24	Sale	950.00	750	712,500	6,380	Aug 26 04:21 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Sale	966.33	3,196	3,088,382	96,940,614	Aug 23 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Proposed Sale	951.97	215,000	204,673,550		Aug 22 12:54 PM
LILLY ENDOWMENT INC	10% Owner	Jul 10 '24	Sale	939.82	210,000	197,361,398	96,943,810	Jul 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 08 '24	Sale	918.64	93,593	85,977,954	97,153,810	Jul 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 05 '24	Sale	915.18	52,369	47,927,194	97,247,403	Jul 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 03 '24	Sale	915.31	8,848	8,098,655	97,299,772	Jul 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 01 '24	Sale	915.26	58,749	53,770,776	97,308,620	Jul 02 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 28 '24	Sale	915.02	1,441	1,318,545	97,367,369	Jul 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 25 '24	Sale	903.82	188,100	170,009,262	97,368,810	Jun 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 24 '24	Sale	902.38	17,229	15,547,068	97,556,910	Jun 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 20 '24	Sale	902.67	9,671	8,729,733	97,574,139	Jun 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 17 '24	Sale	885.91	194,978	172,733,708	97,583,810	Jun 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 14 '24	Sale	882.47	15,022	13,256,490	97,778,788	Jun 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 10 '24	Sale	860.78	75,510	64,997,274	97,793,810	Jun 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 07 '24	Sale	852.29	139,490	118,886,587	97,869,320	Jun 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 06 '24	Sale	837.82	179,617	150,485,878	98,008,810	Jun 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 05 '24	Sale	836.32	20,383	17,046,673	98,188,427	Jun 06 04:00 PM
Rau Diogo	EVP & CIDO	Jun 01 '24	Option Exercise	0.00	6,300	0	14,146	Jun 04 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Jun 03 '24	Sale	829.77	192,794	159,974,050	98,208,810	Jun 04 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Jun 03 '24	Sale	819.47	750	614,602	7,130	Jun 03 04:15 PM
Norton Johna	EVP, Global Quality	Jun 03 '24	Sale	819.38	7,056	5,781,545	25,428	Jun 03 04:14 PM
LILLY ENDOWMENT INC	10% Owner	May 31 '24	Sale	822.11	22,206	18,255,871	98,401,604	Jun 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 29 '24	Sale	811.04	130,385	105,747,975	98,423,810	May 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 28 '24	Sale	809.00	2,052	1,660,068	98,554,195	May 29 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 24 '24	Sale	809.21	92,563	74,902,998	98,556,247	May 28 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 23 '24	Sale	809.99	50,767	41,120,963	98,648,810	May 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 22 '24	Sale	804.18	12,974	10,433,483	98,699,577	May 23 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 21 '24	Sale	805.45	186,259	150,021,694	98,712,551	May 22 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 11 '24	Sale	753.60	750	565,200	7,880	Mar 11 04:27 PM
LILLY ENDOWMENT INC	10% Owner	Feb 16 '24	Sale	780.99	169,684	132,521,930	98,898,810	Feb 20 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 15 '24	Sale	760.46	50,316	38,263,417	99,068,494	Feb 16 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 09 '24	Sale	740.60	206,257	152,753,428	99,118,810	Feb 12 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 08 '24	Sale	740.06	8,743	6,470,336	99,325,067	Feb 09 04:05 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '24	Option Exercise	0.00	4,442	0	26,631	Feb 02 04:32 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '24	Option Exercise	0.00	3,702	0	16,676	Feb 02 04:29 PM
Ricks David A	President, Chair, and CEO	Feb 01 '24	Option Exercise	0.00	29,611	0	455,054	Feb 02 04:28 PM
Jonsson Patrik	EVP&Pres, LLY Dia&Obe, LLY USA	Feb 01 '24	Option Exercise	0.00	4,124	0	41,065	Feb 02 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '24	Option Exercise	0.00	9,941	0	115,262	Feb 02 04:25 PM
Norton Johna	EVP, Global Quality	Feb 01 '24	Option Exercise	0.00	1,268	0	31,382	Feb 02 04:24 PM
Van Naarden Jacob	EVP & Pres., Loxo@Lilly	Feb 01 '24	Option Exercise	0.00	3,618	0	15,463	Feb 02 04:22 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '24	Option Exercise	0.00	4,124	0	62,050	Feb 02 04:20 PM
LILLY ENDOWMENT INC	10% Owner	Jan 31 '24	Sale	648.07	78,573	50,920,924	99,333,810	Feb 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 30 '24	Sale	645.22	76,215	49,175,200	99,412,383	Jan 31 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 29 '24	Sale	645.07	54,032	34,854,422	99,488,598	Jan 30 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 16 '24	Sale	645.60	1,180	761,806	99,542,630	Jan 17 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 11 '24	Sale	634.13	12,344	7,827,686	99,543,810	Jan 12 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 10 '24	Sale	630.59	163,730	103,246,373	99,556,154	Jan 11 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 09 '24	Sale	631.81	34,538	21,821,413	99,719,884	Jan 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 04 '24	Sale	630.28	14,388	9,068,445	99,754,422	Jan 05 02:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience